One hundred and thirty-one consecutive requests for thyroid scintigraphy were analysed to assess their diagnostic contribution to the subsequent medical management of the patient. Forty one per cent ofrequests were to investigate the presence of a clinically detectable solitary nodule and, of these, one fifth had hot nodules. Diffuse goitres accounted for 38% of all referrals, but in only two patients (non-toxic hot nodule) did the results change management. A further 11% of referrals were for multinodular goitres and 8% for retrosternal goitres. In all cases of goitre no additional useful information was obtained from scintigraphy. It is concluded that thyroid scintigraphy was an unnecessary investigation in approximately 45% ofcases. Its primary role was in the investigation ofthe solitary nodule and in detecting toxic nodules in thyrotoxic patients who had no evidence of Graves' disease. Greater discrimination of requests would avoid investigating patients unnecessarily and reduce costs.
Introduction
Radio-iodine-123 scintigraphy is a well established and widely available technique for investigating regional thyroid function.' However, it is a moderately expensive investigation which should be requested only when the result is likely to be of practical benefit. To assess how closely the current pattern of referral adhered to this principle we decided to review all thyroid scintigrams performed by a teaching hospital department over one year, together with clinical details obtained from patients' notes, to identify the reason for referral and contribution made by each scintigram to subsequent clinical management.
Materials and methods
The Nuclear Medicine Department of The General Infirmary at Leeds serves as a referral centre for thyroid scintigraphy for patients in Leeds Western District. Patients were referred to the thyroid clinic either directly by their general practitioner or from hospital clinics within the District. Thyroid scintigraphy was performed two hours after patients had received an intravenous injection of 20 mBq (0.5 mCi) of iodine-123 using a 75 ZLC Siemen's gamma camera.
Results
One hundred and thirty-one consecutive requests were received over one year and grouped according to the reason for scintigraphy, as stated on the request card (Table I ). The median age of patients was 49.0 years ranging from six months to 91 years and 88% of the patients scanned were women. There were more (60%) requests from physicians than surgeons.
Despite the largest number of requests (41 %) being confirmation of the presence of a solitary nodule, this diagnosis was confirmed in only 34 of the 54 referrals. Positive scans comprised 11 hot nodules (4 toxic, 7 non-toxic) and 23 cold nodules. Twenty patients were shown to have other conditions, the most frequent being an asymmetrical but otherwise normal gland ( Table I) .
The second largest category was for further clarification of a clinically palpable diffusely enlarged thyroid gland and this accounted for 38% of referrals (Table I) . Following scintigraphy two patients were found to have non-toxic hot nodules and were therefore kept under review; the remainder of the euthyroid patients were discharged from clinic. Although seven of the patients in this category were thyrotoxic, in no patient could a nodule be palpated, all had diffuse goitres on scintigraphy and scintigraphy did not affect subsequent management.
The diagnosis was confirmed in all 14 patients referred with suspected multinodular goitre on clinical Two patients had large thyroid carcinomas. They had presented with rapidly enlarging, hard, irregular thyroid glands and both scintigrams showed gross disruption of thyroid activity. Surgery had been planned irrespective of the result of scintigraphy.
One patient was suspected of having a lingual thyroid and ectopic thyroid tissue was successfully demonstrated.
Discussion
The current cost of the radioactive iodine-123 isotope used in each thyroid scintigram is £20 per patient. The actual cost to the National Health Service ofincluding physician and technician time and depreciation of equipment probably approaches the fee of £80 levied by private sector hospitals. In view of the reported high incidence (up to 15%) of thyroid disease in the community,2 it is clear that thyroid scintigraphy must be used selectively. The principal and generally accepted indications for thyroid scintigraphy are given in Table II .
The finding of a solitary nodule in the thyroid demands further investigation.3 In most series, this was the largest indication for scintigraphy.46 However, it is suggested that the main role ofscintigraphy is in the thyrotoxic patient, to determine whether overactivity is due to an autonomous hot nodule (Plummer's disease) or diffuse hyperactivity (Graves' disease), to avoid treating patients with Plummer's disease unnecessarily with antithyroid drugs.3'7 Aspiration cytology, without prior scanning, has been claimed to be the most cost-effective method of managing suspected solitary nodules,8'9 but this is not a practical option until cytologists with sufficient expertise are more generally available. Even so, an important argument in favour of scintigraphy for these patients, even before performing fine needle aspiration ifit is available, is to prevent unnecessary investigation of a hot nodule in a euthyroid patient or an asymmetrical normal gland. A recent review of surgical practice, in a district general hospital, indicated that thyroid imaging was still used indiscriminately and made no contribution to the final outcome, because despite the result obtained most 'clinically palpable thyroid nodules' were excised (normal glands were excised in 11% of patients).'" The normal thyroid gland is usually slightly asymmetrical, the right lobe being a little larger than the left and in some patients this asymmetry may simulate nodular enlargement." A normal result on scintigraphy allays the fears of the patient and clinician, prevents unnecessary surgery and thus is of clinical benefit.
The routine use of thyroid imaging in patients with euthyroid goitres, hypothyroidism or suspected nonpalpable nodules has been shown to provide little information beyond that which could be obtained from careful clinical palpation, yet in two recent series, these categories still accounted for nearly half the requests for scintigraphy.4'5 Scintigraphy however, is an essential investigation in the follow-up of patients with differentiated thyroid carcinoma (particularly follicular) to assess the presence or absence of functioning metastases," 4 and for patients with suspected ectopic thyroid tissue.
In conclusion, thyroid scintigraphy should be an essential investigation for patients with thyrotoxicosis, when other features of Graves' disease are absent, to avoid missing an autonomous hot nodule. A uniform policy on the management of patients with solitary nodules needs to be encouraged, but for the present, we would continue to recommend scintigraphy for these patients. However, scintigraphy has been shown to be of little practical value in the management of euthyroid patients with diffuse or multinodular goitres, or patients with hypothyroidism and therefore should not be requested.
Our experience shows that thyroid scintigraphy could be used more selectively and economically and that clinicians should not request this investigation when they know in advance that the outcome will not influence management.
